Myopic choroidal neovascularisation (myopic CNV)

Myopic choroidal neovascularisation (myopic CNV) is one of the most feared complications of myopia, characterised by abnormal blood vessels that grow under the macula and affect the centre of the vision. While myopic CNV is historically thought to only occur in eyes with pathological myopia, it is now recognised that myopic CNV can occur at any degree of myopia and in eyes without typical myopic degenerative fundus changes.

Showing all 3 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Aflibercept KT05V26	PIGF , VEGF-A	Fusion protein	Eylea®	40 mg/mL	–	0,8 mg	-80°C	11/2021	548,10 €	view product Max: 1 Min: 1 Step: 1
Aflibercept KT0KBL2	PIGF , VEGF-A	Fusion protein	Eylea®	40 mg/mL	–	0,8 mg	-80°C	02/2025	1.011,00 €	view product Max: 1 Min: 1 Step: 1
Ranibizumab	VEGF	Biosimilar , Monoclonal Antibody	Ximluci®	10 mg/mL	–	0,21 mg	tba	tba	680,00 €	view product Max: 10 Min: 5 Step: 1